Cargando…
Cytotoxic and Radiosensitising Effects of a Novel Thioredoxin Reductase Inhibitor in Brain Cancers
The thioredoxin (Trx) system, a key antioxidant pathway, represents an attractive target for cancer therapy. This study investigated the chemotherapeutic and radiosensitising effects of a novel Trx reductase (TrxR) inhibitor, IQ10, on brain cancer cells and the underlying mechanisms of action. Five...
Autores principales: | Yao, Anqi, Storr, Sarah J., Inman, Martyn, Barwell, Lucy, Moody, Christopher J., Martin, Stewart G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148287/ https://www.ncbi.nlm.nih.gov/pubmed/35344158 http://dx.doi.org/10.1007/s12035-022-02808-4 |
Ejemplares similares
-
Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancer
por: Abdullah, Nurul A, et al.
Publicado: (2021) -
Thioredoxin Reductase and its Inhibitors
por: Saccoccia, Fulvio, et al.
Publicado: (2014) -
The Impact of p53 Dysfunction in ATR Inhibitor Cytotoxicity and Chemo- and Radiosensitisation
por: Middleton, Fiona K., et al.
Publicado: (2018) -
The Role of Thioredoxin Reductases in Brain Development
por: Soerensen, Jonna, et al.
Publicado: (2008) -
Enzymatic Redox Properties and Cytotoxicity of Irreversible Nitroaromatic Thioredoxin Reductase Inhibitors in Mammalian Cells
por: Nemeikaitė-Čėnienė, Aušra, et al.
Publicado: (2023)